Advertisement

Topics

PulmoXen Reports

11:13 EST 19th December 2018 | BioPortfolio

Advanced Inhalation Therapies AIT Ltd Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 24092018] Prices from USD $250

SummaryAdvanced Inhalation Therapies AIT Ltd AIT, formerly KokiCare Inc is a provider of chronic disease management solutions. The company develops products for bronchiolttis, MABSC, chronic obstructive pulmonary disease, diabetic foot ulcers, stroke and cystic fibrosis. It develops proprietary delivery system that is designed to provide hospitalized patient with a gaseous formulation based on nit...

Nivalis Therapeutics Inc NVLS Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 27092018] Prices from USD $250

SummaryNivalis Therapeutics Inc Nivalis Therapeutics, formerly N30 Pharmaceuticals is a pharmaceutical company that develops a novel class of disease modifying therapies, which can preserve intracellular GSNO in the pathophysiology of cystic fibrosis. The company carries out the discovery, development and commercialization of snitrosothiol drugs. It provides products for the treatment of respirato...

Global Cyclin Dependent Kinase 7 Market Status and Outlook 20182025 [Report Updated: 19082018] Prices from USD $4000

Report SnapshotKey Content of Chapters Including and can be customized, report is a semifinished version, and it takes 4872 hours to upgradePart 1:Terminology Definition, Industry Chain,Industry Dynamics Regulations and Global Market OverviewPart 2:Upstream Raw Materials / Components Manufacturing Procurement Methods Channels and Cost , Major Regional Production Overview and Trade FlowPart 3:Pr...

Vectura Group plc Strategy, SWOT and Corporate Finance Report [Report Updated: 28072018] Prices from USD $175

Vectura Group plc Strategy, SWOT and Corporate Finance ReportSummaryVectura Group plc Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360 view of the company.Key HighlightsVectura Group plc Vectura or 'the gr...

Cystic Fibrosis Foundation Therapeutics Inc Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 13042018] Prices from USD $250

SummaryCystic Fibrosis Foundation Therapeutics Inc Cystic, a subsidiary of Cystic Fibrosis Foundation is a healthcare organization that develops treatments for prevention and control of cystic fibrosis. The organization offers CF and school, CFRD, emotional wellness, fitness, lung transplantation, navigating insurance, nutrition, reproductive health, treatments and therapy services. It offers rese...

Advanced Inhalation Therapies AIT Ltd Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 12042018] Prices from USD $250

SummaryAdvanced Inhalation Therapies AIT Ltd AIT, formerly KokiCare Inc is a provider of chronic disease management solutions. The company develops products for bronchiolttis, MABSC, chronic obstructive pulmonary disease, diabetic foot ulcers, stroke and cystic fibrosis. It develops proprietary delivery system that is designed to provide hospitalized patient with a gaseous formulation based on nit...

Nivalis Therapeutics Inc NVLS Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 23042018] Prices from USD $250

SummaryNivalis Therapeutics Inc Nivalis Therapeutics, formerly N30 Pharmaceuticals is a pharmaceutical company that develops a novel class of disease modifying therapies, which can preserve intracellular GSNO in the pathophysiology of cystic fibrosis. The company carries out the discovery, development and commercialization of snitrosothiol drugs. It provides products for the treatment of respirato...

Advertisement
Quick Search
Advertisement
Advertisement

 

review and buy PulmoXen market research data and corporate reports here